Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxiang Zhengqi Granules
- Development stage
- Unknown
- Lead developer
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Administration
- Oral
01
Overview
Huoxiang Zhengqi Granules is a traditional Chinese patent medicine (CPM) formulation used to treat gastrointestinal disorders, particularly those characterized by 'dampness' and 'summer-heat' in Traditional Chinese Medicine (TCM). The formula is a complex mixture of herbs, typically including *Agastache rugosa*, *Atractylodes lancea*, *Citrus reticulata*, *Magnolia officinalis*, *Platycodon grandiflorus*, *Poria cocos*, and *Glycyrrhiza uralensis*. It is commonly indicated for gastrointestinal flu, heatstroke, and acute gastritis. During the COVID-19 pandemic, Huoxiang Zhengqi Granules was included in Chinese national treatment guidelines and evaluated in clinical registry studies (such as ChiCTR2200059413) for the management of mild COVID-19 symptoms, focusing on its potential to improve recovery rates and viral clearance.
- Brand names
- Huoxiang Zhengqi
- Other names
- Huoxiang Zhengqi Keli藿香正气颗粒
02
Targets
MAPK14 (p38 mitogen-activated protein kinase alpha)MAPK3 (Mitogen-activated protein kinase 1)JNK (Mitogen-activated protein kinase kinase kinase family)PGHS-1 (Prostaglandin G/H Synthase 1)STAT3 (Signal Transducer and Activator of Transcription 3)
Beyond the preview
Go deeper on Huoxiang Zhengqi Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huoxiang Zhengqi Granules.